Shares of Small-cap industrials company EyePoint Pharmaceuticals moved 19.9 this afternoon, and are now trading at $7.21 per share. On the other hand, the average analyst target price for the stock is $31.75.
EyePoint Pharmaceuticals, Inc. focuses on developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders.
EyePoint Pharmaceuticals Investors Should Consider This:
EyePoint Pharmaceuticals has moved 41.0% over the last year.
Its Price to Book (P/B) ratio is 4.32
Focus on EyePoint Pharmaceuticals's Operating Margins
|Date Reported||Total Revenue ($ k)||Net Profit ($ k)||Net Margins (%)|